212 related articles for article (PubMed ID: 26454767)
21. Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases.
Aisner DL; Newell KL; Pollack AG; Kleinschmidt-Demasters BK; Steinberg GK; Smyth LT; Vogel H
Clin Neuropathol; 2014; 33(2):112-21. PubMed ID: 24321241
[TBL] [Abstract][Full Text] [Related]
22. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
23. Epithelioid GBMs show a high percentage of BRAF V600E mutation.
Kleinschmidt-DeMasters BK; Aisner DL; Birks DK; Foreman NK
Am J Surg Pathol; 2013 May; 37(5):685-98. PubMed ID: 23552385
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic xanthoastrocytoma: report of two cases with unconventional clinical presentations.
Vizcaíno MA; Caccamo DV; Fox E; Rodriguez FJ
Clin Neuropathol; 2014; 33(6):380-7. PubMed ID: 25034704
[TBL] [Abstract][Full Text] [Related]
25. BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma.
Koelsche C; Sahm F; Paulus W; Mittelbronn M; Giangaspero F; Antonelli M; Meyer J; Lasitschka F; von Deimling A; Reuss D
Neuropathol Appl Neurobiol; 2014 Apr; 40(3):337-44. PubMed ID: 23822828
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
[TBL] [Abstract][Full Text] [Related]
27. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
Marton E; Feletti A; Orvieto E; Longatti P
J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
[TBL] [Abstract][Full Text] [Related]
28. Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.
Montano N; Papacci F; Cioni B; Gaudino S; Della Pepa GM; Conforti G; Di Bonaventura R; Novello M; Lauriola L; Meglio M
J Clin Neurosci; 2013 Nov; 20(11):1605-8. PubMed ID: 23827171
[TBL] [Abstract][Full Text] [Related]
29. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.
Yeo YH; Byrne NP; Counelis GJ; Perry A
Clin Neuropathol; 2013; 32(3):159-64. PubMed ID: 23196000
[TBL] [Abstract][Full Text] [Related]
30. Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution.
Colin C; Padovani L; Chappé C; Mercurio S; Scavarda D; Loundou A; Frassineti F; André N; Bouvier C; Korshunov A; Lena G; Figarella-Branger D
Neuropathol Appl Neurobiol; 2013 Oct; 39(6):693-705. PubMed ID: 23278243
[TBL] [Abstract][Full Text] [Related]
31. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
[TBL] [Abstract][Full Text] [Related]
32. Pleomorphic xanthoastrocytoma: MR imaging findings in 19 patients.
Yu S; He L; Zhuang X; Luo B
Acta Radiol; 2011 Mar; 52(2):223-8. PubMed ID: 21498352
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
Antonelli M; Buttarelli FR; Arcella A; Nobusawa S; Donofrio V; Oghaki H; Giangaspero F
J Neurooncol; 2010 Sep; 99(2):209-15. PubMed ID: 20174854
[TBL] [Abstract][Full Text] [Related]
34. Targeted therapy for BRAFV600E malignant astrocytoma.
Nicolaides TP; Li H; Solomon DA; Hariono S; Hashizume R; Barkovich K; Baker SJ; Paugh BS; Jones C; Forshew T; Hindley GF; Hodgson JG; Kim JS; Rowitch DH; Weiss WA; Waldman TA; James CD
Clin Cancer Res; 2011 Dec; 17(24):7595-604. PubMed ID: 22038996
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review.
Das S; Yip S; Hukin J; Cochrane D; Dunham C
Clin Neuropathol; 2014; 33(3):190-6. PubMed ID: 24495348
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.
Andrews LJ; Thornton ZA; Saincher SS; Yao IY; Dawson S; McGuinness LA; Jones HE; Jefferies S; Short SC; Cheng HY; McAleenan A; Higgins JPT; Kurian KM
Neuro Oncol; 2022 Apr; 24(4):528-540. PubMed ID: 34718782
[TBL] [Abstract][Full Text] [Related]
38. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
[TBL] [Abstract][Full Text] [Related]
39. Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma.
Giannini C; Hebrink D; Scheithauer BW; Dei Tos AP; James CD
Neurogenetics; 2001 Jul; 3(3):159-62. PubMed ID: 11523567
[TBL] [Abstract][Full Text] [Related]
40. BRAF V600E mutational status in pediatric thyroid cancer.
Henke LE; Perkins SM; Pfeifer JD; Ma C; Chen Y; DeWees T; Grigsby PW
Pediatr Blood Cancer; 2014 Jul; 61(7):1168-72. PubMed ID: 24677749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]